In a 62-year-old patient with anxiety, depression, and insomnia who experienced increased anxiety after increasing citalopram from 20 mg to 30 mg daily, what alternative medication options are appropriate?

Switch to a Different SSRI or Consider Mirtazapine

Given this patient's paradoxical anxiety worsening with citalopram dose escalation, I recommend switching to either sertraline or escitalopram as first-line alternatives, or considering mirtazapine if insomnia remains the predominant concern.

Rationale for Switching from Citalopram

The patient experienced increased anxiety when citalopram was increased from 20 mg to 30 mg daily. This is particularly concerning because:

• Citalopram has specific dose limitations in older adults: The FDA and regulatory agencies have restricted the maximum dose to 40 mg daily due to QT prolongation risks, with further reductions recommended for patients over 60 years 1, 2, 3
• Initial adverse effects of SSRIs can include anxiety or agitation, which may explain this patient's worsening symptoms 1
• At 62 years old, this patient is approaching the age threshold where even lower maximum doses (20 mg) are recommended by some guidelines

First-Line Alternative SSRI Options

Sertraline or Escitalopram

These are the preferred alternative SSRIs for this patient because:

• Both have demonstrated efficacy for anxiety and depression with insomnia 1, 4
• Escitalopram has the least effect on CYP450 isoenzymes compared with other SSRIs, resulting in lower propensity for drug interactions 1
• Sertraline is well-tolerated and has less effect on metabolism of other medications compared to other SSRIs 5
• Recent evidence from 2024 specifically recommends sertraline or escitalopram as first-line for generalized anxiety disorder in older adults 4

Dosing approach: Start with a subtherapeutic "test" dose to minimize initial anxiety/agitation, then increase slowly at 1-2 week intervals 1

Addressing the Insomnia Component

If Insomnia Remains Problematic After SSRI Switch

Mirtazapine emerges as an excellent alternative for this specific clinical scenario:

• Directly addresses both depression/anxiety AND insomnia through its sedating properties 6, 5, 7, 8
• Promotes sleep, appetite, and is well-tolerated 5
• Starting dose: 7.5 mg at bedtime, maximum 30 mg 5
• Particularly useful when insomnia is a prominent feature alongside depression/anxiety 7, 8

Augmentation Strategy for Persistent Insomnia

If switching SSRIs provides adequate mood/anxiety control but insomnia persists, consider adding a sedating agent rather than increasing the antidepressant dose:

Recommended options per guidelines 6, 9:

• Eszopiclone (2-3 mg): Addresses both sleep onset and maintenance insomnia
• Zolpidem (10 mg, or 5 mg in elderly): For sleep onset and maintenance
• Low-dose doxepin (3-6 mg): Specifically for sleep maintenance insomnia
• Trazodone (50 mg): Though guidelines suggest NOT using it 9, it remains widely used clinically for insomnia with depression 6, 7

Important caveat: The 2008 insomnia guideline recommends sedating antidepressants as third-line after benzodiazepine receptor agonists fail, especially when treating comorbid depression/anxiety 6. However, for a 62-year-old, benzodiazepines should be used cautiously due to fall risk and cognitive effects 10.

What NOT to Do

• Do not continue escalating citalopram beyond 30 mg given her age and the paradoxical anxiety response
• Avoid benzodiazepines as first-line in this 62-year-old due to increased risk of falls, cognitive impairment, and dependence 10, 4
• Do not use antihistamines (diphenhydramine) - insufficient evidence and anticholinergic risks in older adults 6, 9
• Avoid trazodone as monotherapy if the primary issue is depression/anxiety rather than insomnia 9

Practical Algorithm

1. Return citalopram to 20 mg (the dose that was tolerated) OR discontinue over 10-14 days to avoid withdrawal 5

2. Switch to sertraline (starting 25-50 mg) or escitalopram (starting 5-10 mg) 5, 4

   • Use a "test dose" approach given her previous anxiety reaction
   • Increase slowly every 1-2 weeks as tolerated

3. If insomnia is the predominant concern, consider mirtazapine 7.5-15 mg at bedtime instead 5, 7, 8

4. If mood/anxiety improves but insomnia persists, add:

   • First choice: Eszopiclone 2 mg or zolpidem 5-10 mg 6, 9
   • Alternative: Low-dose doxepin 3-6 mg for sleep maintenance 9

5. Combine with cognitive behavioral therapy for insomnia (CBT-I) whenever possible, as this provides the most sustained long-term benefit 6, 10

Monitoring Considerations

• Reassess every few weeks initially to evaluate effectiveness and side effects 6
• Monitor for serotonin syndrome if combining medications 1, 3
• Screen for emerging suicidal ideation, particularly during medication transitions
• Consider ECG if QT-prolonging medications are used or if cardiac risk factors present 2